<乌鸦传媒>Minimally Invasive Bariatric Procedure Effective for Milder Obesity Big weight loss seen in patients with mild and moderate levels of obesity Aug 02, 2022
<乌鸦传媒>Dear Insurers: It's Time to Cover Weight Loss Drugs Universal coverage can increase medication access and improve population health Jul 27, 2022
<乌鸦传媒>Keto Versus Mediterranean Diet: Which Is Better for Diabetes? Crossover study looked at cardiometabolic outcomes for each popular diet Jul 08, 2022
<乌鸦传媒>Bye-Bye, 'Life's Simple 7': AHA Redefines Cardiovascular Health by Adding Sleep New metrics and scoring algorithm for heart health in children and adults Jun 29, 2022
<乌鸦传媒>Primary Care Screening Flops in Detecting Diabetic Eye Disease Fundoscopy screening had low sensitivity, accuracy in primary care setting Jun 28, 2022
<乌鸦传媒>Prediabetes May Be an Independent Risk Factor for MI Findings reinforce importance of early screening and intervention, researchers says Jun 12, 2022
<乌鸦传媒>ADA 2022: Racial Residential Segregation, DKA During COVID, and More Noteworthy research presented at the American Diabetes Association annual meeting Jun 08, 2022
<乌鸦传媒>Concerning Trends in Vision Impairment for Adults With Diabetes? Steady decreases in the prevalence of patients with eye problems may be over Jun 07, 2022
<乌鸦传媒>Tirzepatide Reduced Albuminuria in T2D Patients With Heart Risk Subanalysis of SURPASS-4 trial compared the GLP-1/GIP agonist against insulin glargine Jun 06, 2022
<乌鸦传媒>Is Diabetes a Risk Factor for Long COVID? Possibly. Mixed results in seven-study scoping review Jun 05, 2022
<乌鸦传媒>Dulaglutide Improves HbA1c for Youth With Type 2 Diabetes Safety profile consistent with that reported in adults Jun 05, 2022
<乌鸦传媒>Tirzepatide Serves Up Major Weight-Loss Win in Patients With Obesity SURMOUNT-1 trial tested GIP/GLP-1 receptor agonist in people without diabetes Jun 05, 2022
<乌鸦传媒>No Cardioprotection Seen With Long-Term Metformin or Lifestyle Intervention Both approaches "highly effective" in T2D, but not for preventing CV disease, expert says May 24, 2022
<乌鸦传媒>Diabetic Pain Relief Lasts With High Frequency Spinal Cord Stimulation Trial followed patients with Senza System for 18 months May 16, 2022
<乌鸦传媒>Patients With Type 2 Diabetes and CKD Face Poor COVID Outcomes Severity of kidney disease ups risk of ICU time, in-hospital mortality, and more May 15, 2022
<乌鸦传媒>First GLP-1/GIP Receptor Agonist OK'd for Type 2 Diabetes Injectable tirzepatide lands approval as an adjunct to diet and exercise May 13, 2022
<乌鸦传媒>How Often Does Prediabetes in Seniors Escalate to Full-Blown Disease? Study finds estimated annual progression rate to diabetes of 5.3% Apr 20, 2022
<乌鸦传媒>Who Is Really Driving Up Insulin Costs? More attention needs to focus on pharmaceutical middlemen Apr 18, 2022
<乌鸦传媒>In Type 2 Diabetes, Metabolic Control Could Add Years to Life Controlling four biomarkers could add as much as a decade to life expectancy Apr 18, 2022
<乌鸦传媒>The Winners and Losers of the Proposed Insulin Cost Cap While it benefits some, the $35 cap is only a stopgap measure Apr 08, 2022
<乌鸦传媒>Which Anticonvulsant Mood Stabilizer Upped Diabetes Risk? Observational study looked at 5-year risk differences between four agents Apr 06, 2022
<乌鸦传媒>GLP-1 Receptor Agonists: How Safe Are They for the Gallbladder? Link with gallbladder, biliary diseases could be due to weight loss associated with class of drug Mar 28, 2022
<乌鸦传媒>E-Cig Use Tied to Higher Odds of Prediabetes As in regular cigarettes, nicotine may play a role, researcher says Mar 03, 2022
<乌鸦传媒>Gastric Bypass Most Cost-Effective for Severe Obesity, T2D? Modeling study compares Roux-en-Y, conventional medical therapy, and sleeve gastrectomy Feb 14, 2022
<乌鸦传媒>FDA OKs 180-Day Implantable Continuous Glucose Monitor Senseonics' Eversense E3 System approved for adults with diabetes Feb 11, 2022
<乌鸦传媒>Obesity More Common in Type 1 Diabetes Than Expected And this is putting the population at a higher risk for chronic kidney disease, researchers say Jan 26, 2022
<乌鸦传媒>Weight-Loss Drug Wegovy Exceeded Expectations, and Supply Since its June approval, the injectable flew off shelves and into short supply Dec 29, 2021
<乌鸦传媒>Use of GLP-1 Receptor Agonists Scarce in Type 2 Diabetes Particularly so for racial/ethnic minority populations Dec 17, 2021
<乌鸦传媒>Wide Racial Gap for Diabetes Tech Use Among Medicare Patients Insulin pump and CGM use significantly lower among black patients Dec 15, 2021
<乌鸦传媒>Digital HTN, Diabetes Monitoring Program a Boon for Patients Program reports growth and better outcomes Dec 09, 2021
<乌鸦传媒>Another Study Confirms Gout Benefit With SGLT2 Inhibitors Gout risk reduction was significantly better than with DPP-4 inhibitors Nov 19, 2021
<乌鸦传媒>More Good News for Empagliflozin in Patients With Heart Failure Slower renal function decline with SGLT-2 inhibitor in EMPEROR-Preserved trial Nov 06, 2021
<乌鸦传媒>Diuretic Bolstered Blood Pressure Control in Advanced CKD But some safety signals did arise in 12-week trial Nov 05, 2021
<乌鸦传媒>Liraglutide After Gastric Bypass Helped Stave Off Weight Regain The GLP-1 receptor agonist kept patients closer to nadir weight versus lifestyle management alone Nov 04, 2021
<乌鸦传媒>No Benefit to Intensifying Diabetes Meds at Hospital Discharge Older adults discharged with intensified regimen had higher risk of severe hypoglycemia Oct 21, 2021
<乌鸦传媒>FDA Nudges Restaurants, Food Manufacturers to Cut Sodium Voluntary guidance aims to reduce Americans' sodium intake by 12% Oct 13, 2021
<乌鸦传媒>Insulins: Out With the Old, In With the New Patients with diabetes embraced insulin analogs, pen-based delivery over 5-year period Oct 12, 2021
<乌鸦传媒>Early Steroid Switch May Improve Visual Acuity for Some DME Patients Significant improvement in vision, retinal thickening after inadequate response to anti-VEGF Oct 11, 2021
<乌鸦传媒>Back-to-Back Recalls for Medtronic Insulin Pumps Class I recalls on 600 series pumps and 500 series remotes Oct 06, 2021
<乌鸦传媒>Fewer Deaths After Sleeve Gastrectomy Versus Gastric Bypass Authors estimate about 540 fewer deaths at 5 years if all patients chose sleeve Oct 06, 2021
